192 related articles for article (PubMed ID: 3799745)
1. Chorionic biopsy in management of severe Kell alloimmunization.
Rodesch F; Lambermont M; Donner C; Simon P; Romasco F; Schwers J; Wybran J
Am J Obstet Gynecol; 1987 Jan; 156(1):124-5. PubMed ID: 3799745
[TBL] [Abstract][Full Text] [Related]
2. Kell alloimmunization, hemolytic disease of the newborn, and perinatal management.
Wenk RE; Goldstein P; Felix JK
Obstet Gynecol; 1985 Oct; 66(4):473-6. PubMed ID: 3931011
[TBL] [Abstract][Full Text] [Related]
3. [Perinatal research on feto-maternal anti-Kell immunization].
Gavriil P; Jauniaux E; Lambermont M; Donner C; Avni FE; Rodesch F
J Gynecol Obstet Biol Reprod (Paris); 1989; 18(6):761-4. PubMed ID: 2689503
[TBL] [Abstract][Full Text] [Related]
4. [Kell alloimmunization in pregnancy].
Gariod S; Brossard Y; Poissonnier MH; Vuilliez B; Deutsch V; Jouk PS; Pons JC
J Gynecol Obstet Biol Reprod (Paris); 2004 Nov; 33(7):637-48. PubMed ID: 15550883
[TBL] [Abstract][Full Text] [Related]
5. Fetal blood group determination in first-trimester pregnancy for the management of severe immunization.
Kanhai HH; Gravenhorst JB; Gemke RJ; Overbeeke MA; Bernini LF; Beverstock GC
Am J Obstet Gynecol; 1987 Jan; 156(1):120-3. PubMed ID: 3099576
[TBL] [Abstract][Full Text] [Related]
6. [Serologic incompatibility and family planning].
Matýsek P; Ungerová A; Cuprová M; Muchová M
Cesk Gynekol; 1988 Aug; 53(7):497-9. PubMed ID: 3168017
[No Abstract] [Full Text] [Related]
7. Pregnancy outcome in mothers who develop Kell antibodies.
Farr V; Gray E
Scott Med J; 1988 Aug; 33(4):300-3. PubMed ID: 3055288
[TBL] [Abstract][Full Text] [Related]
8. [Prenatal fetal blood group determination using chorionic villi biopsy].
Kanhai HH; Gemke RJ; Overbeeke MA; Bernini LF; Beverstock GC; Bennebroek Gravenhorst J
Ned Tijdschr Geneeskd; 1989 Apr; 133(16):819-21. PubMed ID: 2498672
[TBL] [Abstract][Full Text] [Related]
9. [Hemolytic disease of the newborn due to Kell sensitization].
Beller U; Hochner-Celnikier D; Ron M; Palti Z; Beyth Y
Harefuah; 1981 Jul; 101(1-2):14-5. PubMed ID: 7319365
[No Abstract] [Full Text] [Related]
10. [Blood transfusion complications due to Kell factor incompatibility of the transfused blood].
Skachilova NN; Umnova MA; Morozova AD; Shakhsuvarov VD; Beliaev VV
Probl Gematol Pereliv Krovi; 1982 Dec; 27(12):16-20. PubMed ID: 7156084
[No Abstract] [Full Text] [Related]
11. [Kell antibodies in pregnancy].
Rempen A; Schweppe KW
Z Geburtshilfe Perinatol; 1983; 187(4):183-90. PubMed ID: 6684844
[TBL] [Abstract][Full Text] [Related]
12. [Kell immunization--a case report].
Tasić M; Milosević J; Stefanović M; Radović-Janosević D; Krstić M; Antić V
Med Pregl; 2009; 62(7-8):369-72. PubMed ID: 19902791
[TBL] [Abstract][Full Text] [Related]
13. Percutaneous umbilical blood sampling in the management of Kell isoimmunization.
Copel JA; Scioscia A; Grannum PA; Romero R; Reece EA; Hobbins JC
Obstet Gynecol; 1986 Feb; 67(2):288-90. PubMed ID: 3945439
[TBL] [Abstract][Full Text] [Related]
14. [Hemolytic disease of the newborn due to anti-Ku (author's transl)].
Huang HJ; Tagawa H
Nihon Sanka Fujinka Gakkai Zasshi; 1982 Jan; 34(1):119-21. PubMed ID: 7199551
[No Abstract] [Full Text] [Related]
15. Severe erythroblastosis fetalis secondary to anti-Kpb sensitization.
Dacus JV; Spinnato JA
Am J Obstet Gynecol; 1984 Dec; 150(7):888-9. PubMed ID: 6507516
[No Abstract] [Full Text] [Related]
16. Kell sensitization in pregnancy.
Caine ME; Mueller-Heubach E
Am J Obstet Gynecol; 1986 Jan; 154(1):85-90. PubMed ID: 3946507
[TBL] [Abstract][Full Text] [Related]
17. Obstetric history and antibody titer in estimating severity of Kell alloimmunization in pregnancy.
van Wamelen DJ; Klumper FJ; de Haas M; Meerman RH; van Kamp IL; Oepkes D
Obstet Gynecol; 2007 May; 109(5):1093-8. PubMed ID: 17470588
[TBL] [Abstract][Full Text] [Related]
18. Kell sensitization in pregnancy.
Bowman JM
Am J Obstet Gynecol; 1986 Oct; 155(4):912-4. PubMed ID: 3766648
[No Abstract] [Full Text] [Related]
19. Erythroblastosis fetalis produced by anti-k.
Bowman JM; Harman FA; Manning CR; Pollock JM
Vox Sang; 1989; 56(3):187-9. PubMed ID: 2728396
[TBL] [Abstract][Full Text] [Related]
20. [Rapid and severe development of fetal hemolytic disease due to anti-Kell antibodies].
Frère MC; Schaaps JP; Thoumsin H; Retz MC; Rif J; Rigo J; De Cortis T; Lambotte R; Senterre J; Sondag-Thull D
Rev Med Liege; 1995 Feb; 50(2):63-6. PubMed ID: 7899747
[No Abstract] [Full Text] [Related]
[Next] [New Search]
